Dr. Wu’s goal is to develop new immune-based treatments for chronic lymphocytic leukemia (CLL).  Current treatments for CLL are effective for a short time, but patients ultimately relapse and die of their disease.  Her studies focus on how the immune system can be enlisted in the treatment of cancer.  She is designing a tumor-specific immunotherapy with minimal side effects that will target the leukemia cells and ultimately lead to a non-toxic therapy to cure CLL.

---

Project Title: "Developing adoptive cellular therapy for the treatment of CLL"

Institution: Dana-Farber Cancer Institute

Sponsor(s) / Mentor(s): Jerome Ritz, MD

Cancer Type: Leukemias

Research Area: Tumor Immunology